World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
23692
World Ranking
17523
National Ranking
199

Overview

Caj Haglund is a researcher affiliated with the University of Helsinki in Finland. Their scholarly work is primarily situated within the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to Oncology, Surgery, Molecular Biology, Cancer Research, and Immunology as key subfields.

Their research topics include:

  • Pancreatic and Hepatic Oncology Research
  • Genetic factors in colorectal cancer
  • Pancreatitis Pathology and Treatment
  • Head and Neck Cancer Studies
  • Inflammatory Biomarkers in Disease Prognosis
  • Cancer Cells and Metastasis
  • Peptidase Inhibition and Analysis

Haglund has published papers in several notable scientific journals, with recurrent contributions to venues such as Scientific Reports, Oncology, HPB, Cancers, and Tumor Biology.

Recent publications by Haglund include:

  • "Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group" (2022) published in British Journal of Cancer
  • "Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer" (2020) published in Acta Oncologica
  • "CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242" (2021) published in Tumor Biology
  • "Stromal categorization in early oral tongue cancer" (2020) published in Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • "The prognostic role of tissue TLR2 and TLR4 in colorectal cancer" (2020) published in Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

Collaboration is notable in Haglund's work, with frequent co-authors including:

  • Jaana Hagström
  • Hanna Seppänen
  • Harri Mustonen
  • Antti Mäkitie
  • Tuomas Kaprio

The scientist's body of work demonstrates a focus on cancer biology, biomarker development, and clinical prognostic factors. The integration of molecular biology and immunology perspectives reflects in research on tumor microenvironment and inflammatory biomarkers.

Haglund's publication record includes a broad range of research articles contributing to the understanding of tumor pathology, cancer prognosis, and treatment pathways, particularly in pancreatic, hepatic, colorectal, and head and neck cancers.

Best Publications

  • Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

    Ari Ristimäki;Anna Sivula;Johan Lundin;Mikael Lundin

  • Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

    M.J. Duffy;A. van Dalen;C. Haglund;L. Hansson

  • Deep learning based tissue analysis predicts outcome in colorectal cancer

    Dmitrii Bychkov;Nina Linder;Nina Linder;Riku Turkki;Stig Nordling

  • National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

    Catharine M. Sturgeon;Michael J. Duffy;Ulf Håkan Stenman;Hans Lilja

  • Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.

    M.J Duffy;A van Dalen;C Haglund;L Hansson

  • Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report

    M.J. Duffy;C. Sturgeon;R. Lamerz;C. Haglund

  • Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry

    M Carpelan-Holmström;S Nordling;E Pukkala;R Sankila

  • Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update

    M.J. Duffy;R. Lamerz;C. Haglund;A. Nicolini

  • Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus

    Christianne J. Buskens;Bastiaan P. van Rees;Anna Sivula;Johannes B. Reitsma

  • CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.

    M Carpelan-Holmström;J Louhimo;U H Stenman;H Alfthan

  • Cytoplasmic HuR Expression Is a Prognostic Factor in Invasive Ductal Breast Carcinoma

    Mira Heinonen;Petri Bono;Kirsi Narko;Sung-Hee Chang

  • MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric Cancer

    Anchit Khanna;Camilla Böckelman;Annabrita Hemmes;Melissa R. Junttila

  • Transcription Factor PROX1 Induces Colon Cancer Progression by Promoting the Transition from Benign to Highly Dysplastic Phenotype

    Tatiana Petrova;Antti Nykänen;Camilla Norrmen;Konstantin I Ivanov

  • Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases

    Hannu Jalanko;Pentti Ilmari Kuusela;Peter J. Roberts;Pentti Ilmari Sipponen

  • Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.

    Johanna Mrena;Jan-Patrik Wiksten;Alexandra Thiel;Arto Kokkola

  • Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.

    Ari Ristimäki;Outi Nieminen;Kirsi Saukkonen;Kristina Hotakainen

  • Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma.

    Tiina-Liisa Erkinheimo;Heini Lassus;Anna Sivula;Sibani Sengupta

  • Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women.

    Henrik V Alfthan;Caj Hilding Haglund;Jan Dabek;Ulf Håkan Evald Stenman

  • Cyclooxygenase-2 and gastric carcinogenesis.

    Kirsi Saukkonen;Johanna Rintahaka;Anna Sivula;Christianne J. Buskens

  • Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.

    Caj Hilding Haglund

Frequent Co-Authors

Ari Ristimäki
Ari Ristimäki University of Helsinki
Ulf-Håkan Stenman
Ulf-Håkan Stenman University of Helsinki
Timo Sorsa
Timo Sorsa University of Helsinki
Tuula Salo
Tuula Salo University of Helsinki
Pentti Kuusela
Pentti Kuusela University of Helsinki
Risto Renkonen
Risto Renkonen University of Helsinki
Kari Alitalo
Kari Alitalo University of Helsinki
Leif C. Andersson
Leif C. Andersson University of Helsinki
Olli Carpén
Olli Carpén University of Helsinki
Stina Syrjänen
Stina Syrjänen University of Turku

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine or looking to advance your career, online degrees offer flexible options to match your goals. Nursing professionals, for instance, may benefit from exploring rn to bsn programs no clinicals. These programs can expedite degree completion without the need for traditional in-person clinical hours, making them ideal for working nurses.

For those aiming for roles in advanced nursing practice or leadership, the fastest msn to dnp program options allow experienced nurses to earn doctoral credentials in less time through intensive online coursework. Alternatively, budget-conscious students may prefer to look into the cheapest online dnp programs, balancing affordability and accreditation without sacrificing quality.

If you’re seeking a faster entry into the nursing profession, accelerated lpn programs provide fast-track pathways to start working sooner. With so many accredited online healthcare degrees now available, you can find a pathway that fits your schedule, budget, and career ambitions while still advancing in the dynamic medical field.

Best Scientists Citing Caj Haglund

Trending Scientists

Recently Published Articles